来自MSN53 分钟
'East to West': AdAlta unveils new strategy to find drug candidates, but appears to've ...
AdAlta (ASX:1AD) has unveiled a new grand plan to take cell therapy candidates from Southeast Asia, firm them up in Australian early-stage tests, and then licence those products if successful to ...